Our study highlights several canonical and non-canonical signaling pathways that, when experimentally activated, are capable of modulating sensitivity to MEK and FAK inhibition, outlining a network of potential adaptive signaling responses in uveal melanoma cells. Here, PTK2 is linked to uveal melanoma.